Navigation Links
Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Date:5/22/2008

Barry D. Quart, PharmD, Ardea Biosciences' President and CEO. "In addition, the excellent preclinical properties of RDEA427 and its long half-life in humans make it the perfect candidate to progress into clinical testing. Developing both RDEA806 and RDEA427 in tandem is consistent with our business strategy of keeping Ardea's pipeline full of novel compounds in areas that are underserved by current treatment options. We are on track to begin a Phase 1 trial with RDEA427 later this year, and expect to initiate a Phase 2b trial with RDEA806 in the third quarter of this year."

About RDEA806 and RDEA427

RDEA806 and RDEA427 are novel, structurally different NNRTIs for the potential treatment of HIV infection. Based on preclinical and clinical studies to-date, Ardea believes that RDEA806 and RDEA427 may have important competitive advantages. These include: the potential for potent antiviral activity against a wide range of HIV viral isolates, including those that are resistant to efavirenz (Sustiva(R), Bristol-Myers Squibb); a high genetic barrier to resistance; the potential to be administered in a patient-friendly, oral dosing regimen; limited pharmacokinetic interactions with other drugs; and the ability to be co-formulated with other HIV antiviral drugs. RDEA806 reproductive toxicity data indicates that future studies, including Ardea's planned Phase 2b trial, would likely include women of child-bearing age in anti-retroviral naive HIV-infected patients.

About Ardea Biosciences

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout. We have four drug candidates in clinical trials and others in preclinical development and discovery. Our most advanced development candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which is in a Phase 2a study for
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
2. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
3. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
4. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
5. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
6. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
11. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... 25, 2015  With the introduction of Elekta,s new ... radiosurgery are now available for more patients with a ... generation stereotactic radiosurgery system for the brain, integrates advanced ... the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell ... ESTRO Forum in Barcelona . ...
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching ... cronuts: 1-800 CONTACTS announces their new Apple Watch app which ... Two taps. New contacts. From your watch. ... also features LensGauge which helps keep track of how long ... reorder. "Since our inception, we,ve been dedicated to ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ... its rejection of the unsolicited offer from Mylan NV ... the outstanding shares of Perrigo for $60.00 per share ... ordinary Perrigo share (the "Offer").  The ... per share significantly undervalued the Company and its future ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
... The Barbara Ann Karmanos Cancer Institute announced today that its spin-off ... capital to start the commercialization process of SoftVue, an alternative to mammography. ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) , ... SoftVue is a tomographic ultrasound imaging and ...
... 24 Genzyme Corp. has signed a consent decree agreeing to correct manufacturing ... to the federal government $175 million in unlawful profits from the sale ... announced today. , , , ... , , ...
Cached Medicine Technology:Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 2Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 3Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 4Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 5Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
(Date:4/27/2015)... FL (PRWEB) April 27, 2015 Puroast Coffee ... nationwide tour for 2015. The BattleFrog OCR is a ... created to both educate participants in the training that Seals ... “We are thrilled to be able to sponsor the BattleFrog ... unique fitness experience that we find well-suited to give people ...
(Date:4/27/2015)... OR (PRWEB) April 27, 2015 Climate ... Their accuracy depends on the number of variables used ... Recently, two noted scientists, water researcher Gerald Pollack, PhD, ... Kleyne Hour™ Power of Water® radio show, noted three ... simulations. , None of these individuals dispute that ...
(Date:4/27/2015)... The Radiology Business Management Association (RBMA) ... business information and intelligence, is proud to announce the ... for its more than 2,000 members. , “RBMA Washington ... sources in that it is exclusively devoted to national ... The newsletter is produced in cooperation with Thorn Run ...
(Date:4/27/2015)... Cambia Health Solutions is pleased ... team as Operating Partner within its Direct Health ... and building companies that change the way people experience ... will be responsible for accelerating Cambia’s investments, which are ... both economically sustainable and person-focused, while looking for new ...
(Date:4/27/2015)... Health conscious businesses in the Madison and ... on their doorstep, which will offer a wide range ... low-carbohydrate diets. This nut-based bakery will provide ... will use only natural sweeteners like honey and fruit. ... provide specialty food that is currently not commonplace in ...
Breaking Medicine News(10 mins):Health News:Puroast Coffee on Tour with BattleFrog 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2
... Averting second, possibly deadly, attack is long-term goal, researchers say ... developed a tool to predict whether a patient will suffer ... , "This is an important new tool because studies have ... a first stroke are more likely to die or have ...
... University of Florida researchers at work on a malaria elimination ... spread of the disease using cell phone records. The ... often residents of Zanzibar travel and where they go. A ... Tanzania in East Africa, Zanzibar has drastically reduced malaria in ...
... found, , WEDNESDAY, Dec. 16 (HealthDay News) -- E. coli ... the stomach pain and diarrhea that result -- might also ... have found the same strains of the bacteria in chicken ... , There,s no evidence that the germs were transmitted ...
... 8 percent of children are uninsured, government report finds , ... months of this year, 45.4 million Americans of all ages ... health insurance, according to new National Health Interview Survey statistics ... of all ages had been uninsured for at least part ...
... , NEW ORLEANS, Dec. 16 A new ... takes for inpatient healthcare facilities to calculate their staffing needs ... Census allows inpatient healthcare facilities to calculate their mandatory ... and receive a daily report as to how it affects ...
... DNA of a 1st century shrouded man found in a tomb ... the earliest proven case of leprosy. Details of the research will ... The molecular investigation was undertaken by Prof. Mark Spigelman and ... the Study of Infectious and Tropical Diseases at the Hebrew University ...
Cached Medicine News:Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3
The Bovie IDS Series are the latest electrosurgical generators with fully digital implementation....
Elmed electrosurgical systems for major surgery....
Jewelers bipolar forceps, 10 cm....
European bipolar foot activated forceps....
Medicine Products: